Development of therapeutics for high grade gliomas using orthotopic rodent models

Research output: Contribution to journalArticlepeer-review


To study novel treatments for high grade gliomas (WHO grade III and IV) we need animal models of those disorders. Orthotopic tumors in mouse or rats seem at present the most reliable in vivo glioma model in order to develop specific therapies. The orthotopic tumor characteristics should yet closely mimic the human glioma features (in particular infiltrating growth and neovascularization). In this regard, glioma cell lines with stem properties (glioma stem cells - GSC) may fulfill at best those needs. Orthotopic gliomas developed from some widely used, established non-stem cell lines showing poor infiltrating capacity are not suitable. Therapeutic and diagnostic procedures recently developed using orthotopic rodent glioma tumors along their potentialities and pitfalls are analyzed.

Original languageEnglish
Pages (from-to)3272-3299
Number of pages28
JournalCurrent Medicinal Chemistry
Issue number26
Publication statusPublished - Sep 2013


  • Brain tumor
  • Cell cycle
  • Glioblastoma
  • Radiotherapy
  • Resistance and in vivo
  • Temozolomide

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology


Dive into the research topics of 'Development of therapeutics for high grade gliomas using orthotopic rodent models'. Together they form a unique fingerprint.

Cite this